Latest Period
Q1 2026
Security Snapshot
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) Institutional Ownership
CUSIP: 05156V102
13F Institutional Holders and Ownership History from Q3 2014 to Q1 2026
Institutions Reporting
258
Shares (Excl. Options)
73,903,308
Price
$14.82
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, no par value
- Symbol
- AUPH on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 73,903,308
- Total 13F value
- $1,094,982,406
- Portfolio coverage rank
- 0%
- Share change
- +2,764,662
- Value change
- +$38,656,689
- Number of holders
- 258
- Shares outstanding
- 130,441,060
- SEC-reported price per share
- $16.03
- Insider filing price
- $16.03
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value is tracked under CUSIP 05156V102.
- 258 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 255 to 258 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,153,064,464 to $1,094,982,406.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 258 institutions filings for Q1 2026.
Security key
05156V102
Latest holder period
Q1 2026
13F holders
258
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
AUPH full holder history
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Aurinia Pharmaceuticals Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05156V102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
AUPH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 10% | +8.9% | $209,097,019 | +$13,058,134 | 13,044,106 | +6.7% | TANG CAPITAL MANAGEMENT, LLC | 02 Jun 2026 |
| ILJIN SNT Co., Ltd. | 5% | $57,509,241 | 6,535,141 | Chin Kyu Huh | 11 Aug 2025 | |||
| ARMISTICE CAPITAL, LLC | 4.5% | $51,840,000 | 6,400,000 | Armistice Capital, LLC | 31 Dec 2024 |
As of 31 Mar 2026, 258 institutional investors reported holding 73,903,308 shares of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH). This represents 57% of the company’s total 130,441,060 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
42%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.4% | 12,229,500 | +7.9% | 9.2% | $181,241,190 |
| BlackRock, Inc. | 6% | 7,845,521 | -1% | 0% | $116,270,621 |
| NEA Management Company, LLC | 3% | 3,969,834 | 0% | 3.3% | $58,832,940 |
| TWO SIGMA INVESTMENTS, LP | 2.6% | 3,428,705 | +75% | 0.04% | $50,813,408 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.5% | 3,284,368 | -3% | 0.03% | $48,674,334 |
| STATE STREET CORP | 1.9% | 2,527,099 | +1% | 0% | $37,451,607 |
| MORGAN STANLEY | 1.7% | 2,232,548 | +0.71% | 0% | $33,086,365 |
| MARSHALL WACE, LLP | 1.4% | 1,874,597 | +19% | 0.03% | $27,781,530 |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 1,663,835 | +4.6% | 0.04% | $24,658,035 |
| D. E. Shaw & Co., Inc. | 1.2% | 1,572,983 | +2.7% | 0.02% | $23,311,608 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 1,536,009 | +1.9% | 0% | $22,760,482 |
| GOLDMAN SACHS GROUP INC | 1.1% | 1,433,508 | +42% | 0% | $21,244,588 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.96% | 1,256,361 | 0% | 0% | $18,619,270 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.84% | 1,097,189 | -3.7% | 0.07% | $16,260,341 |
| LSV ASSET MANAGEMENT | 0.8% | 1,039,576 | +58% | 0.03% | $15,407,000 |
| NOMURA HOLDINGS INC | 0.74% | 968,910 | -16% | 0.15% | $14,359,246 |
| Man Group plc | 0.73% | 951,412 | +12% | 0.03% | $14,099,926 |
| AQR CAPITAL MANAGEMENT LLC | 0.73% | 948,810 | +97% | 0.01% | $14,061,365 |
| Qube Research & Technologies Ltd | 0.71% | 930,631 | +6.4% | 0.02% | $13,791,951 |
| NORTHERN TRUST CORP | 0.63% | 824,105 | +3% | 0% | $12,213,236 |
| JUPITER ASSET MANAGEMENT LTD | 0.62% | 803,419 | -11% | 0.06% | $11,906,670 |
| JANUS HENDERSON GROUP PLC | 0.58% | 757,435 | +9.7% | 0.01% | $11,225,433 |
| BNP PARIBAS FINANCIAL MARKETS | 0.57% | 748,765 | 0% | 0.01% | $11,096,697 |
| Nuveen, LLC | 0.5% | 653,424 | -1.8% | 0% | $9,683,743 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.47% | 615,091 | +4.7% | 0.01% | $9,115,648 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
47
Latest
Q1 2026
Rows shown
1-25 of 47
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 73,903,308 | $1,094,982,406 | +$38,656,689 | $14.82 | 258 |
| 2025 Q4 | 72,327,981 | $1,153,064,464 | +$82,916,910 | $15.95 | 255 |
| 2025 Q3 | 65,698,350 | $726,012,410 | +$84,257,823 | $11.05 | 240 |
| 2025 Q2 | 58,318,900 | $494,168,918 | -$31,810,462 | $8.47 | 216 |
| 2025 Q1 | 62,001,205 | $498,579,335 | +$33,892,897 | $8.04 | 210 |
| 2024 Q4 | 57,799,592 | $519,061,476 | +$4,097,220 | $8.98 | 197 |
| 2024 Q3 | 57,639,569 | $422,207,215 | +$21,955,759 | $7.33 | 180 |
| 2024 Q2 | 55,307,620 | $315,754,570 | +$4,958,367 | $5.71 | 168 |
| 2024 Q1 | 54,674,386 | $273,920,542 | +$3,860,760 | $5.01 | 173 |
| 2023 Q4 | 53,220,649 | $478,436,427 | +$38,734,205 | $8.99 | 186 |
| 2023 Q3 | 50,339,448 | $391,141,750 | -$739,167 | $7.77 | 194 |
| 2023 Q2 | 49,820,766 | $482,543,239 | -$1,739,141 | $9.68 | 197 |
| 2023 Q1 | 49,994,676 | $547,934,449 | +$7,051,204 | $10.96 | 182 |
| 2022 Q4 | 51,117,260 | $220,815,199 | -$24,246,473 | $4.32 | 181 |
| 2022 Q3 | 55,353,711 | $416,255,629 | +$28,431,118 | $7.52 | 177 |
| 2022 Q2 | 50,117,033 | $503,590,633 | +$74,385,031 | $10.05 | 191 |
| 2022 Q1 | 42,164,731 | $521,893,499 | +$1,302,371 | $12.38 | 176 |
| 2021 Q4 | 38,512,517 | $881,056,850 | -$105,784,806 | $22.87 | 180 |
| 2021 Q3 | 43,124,514 | $954,392,864 | -$114,507 | $22.13 | 160 |
| 2021 Q2 | 49,010,949 | $635,371,815 | -$42,000,595 | $12.96 | 162 |
| 2021 Q1 | 52,072,235 | $676,156,911 | -$80,619,096 | $12.99 | 163 |
| 2020 Q4 | 57,920,959 | $801,022,755 | -$114,549,555 | $13.83 | 139 |
| 2020 Q3 | 64,784,594 | $954,040,391 | +$75,038,433 | $14.73 | 144 |
| 2020 Q2 | 58,637,850 | $953,206,339 | -$24,791,270 | $16.25 | 127 |
| 2020 Q1 | 60,307,130 | $875,021,915 | +$158,173,274 | $14.51 | 122 |